Assignee
SFERA ADONIS
US·0 granted patents·3 pending applications·0 citations·filing 2024–2024
Top patents by PatentIndex Score
3 records- 0140US2024277809A1F-652 (recombinant human interleukin-22) for treatment of schizophrenia and psychosisSFERA ADONIS·Filed 2024·Application pending·0 cites
- 0240US2024382500A1Dopamine receptor agonists or angiotensin receptor blockers or combinations thereof for covid-19 sequelaeSFERA ADONIS·Filed 2024·Application pending·0 cites
- 0339US2024374625A1Treatment of schizophrenia with pdk1 inhibition by combining pdk1 inhibitors with lipid replacement therapySFERA ADONIS·Filed 2024·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SFERA ADONIS files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →